| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/29/2006 | US7098337 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098316 Isolated nucleic acid, coding regions of genes of proteins, vectors, host cells and genetic engineering for producing proteins and diagnosis of diseaes |
| 08/29/2006 | US7098248 Beta-adrenergic blockade reversal of catabolism after severe burn |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098235 Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds |
| 08/29/2006 | US7098230 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/29/2006 | US7098229 (+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 08/29/2006 | US7098219 Inhibitors of cellular efflux pumps of microbes |
| 08/29/2006 | US7098218 7,8,9, or 10-sulfamyl, (thio)phosphonyl, sulfonyl, or sulfonamido-naphth[2,1-f]isoquinolin-1,3-diones; drug screening; enzyme inhibitors; anticarcinogenic agents |
| 08/29/2006 | US7098214 Dopamine D3 receptor ligands or antagonists for use in the treatment of renal function disorders |
| 08/29/2006 | US7098200 Analgesics |
| 08/29/2006 | US7098012 DNA demethylase, therapeutic and diagnostic uses thereof |
| 08/29/2006 | US7097998 Aβ42 lowering agents |
| 08/29/2006 | US7097994 UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GaINAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 08/29/2006 | US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 08/29/2006 | US7097859 Indium supplement compositions and methods therefor |
| 08/29/2006 | US7097845 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 08/29/2006 | US7097838 Antagonists of HMG1 for treating inflammatory conditions |
| 08/29/2006 | US7097823 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); osteomyelitis treatment |
| 08/29/2006 | CA2255615C Compositions comprising conjugates of cis-docosahexaenoic acid and docetaxel |
| 08/29/2006 | CA2233677C A novel combination of a .beta.-receptor blocker and an opioid |
| 08/29/2006 | CA2213996C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 08/29/2006 | CA2131515C Effervescent mixture with alkali metal salts or lysinates of acidic, insoluble or slightly soluble active ingredients |
| 08/24/2006 | WO2006089005A2 Combination of selective factor viia and/or xia and plasma kallikrein inhibitors |
| 08/24/2006 | WO2006088748A2 Method for treating obesity |
| 08/24/2006 | WO2006088219A1 Il-13 production inhibitor |
| 08/24/2006 | WO2006088088A1 Pain remedy containing rock inhibitor |
| 08/24/2006 | WO2006087997A1 1-SUBSTITUTED-7-(β-D-GLYCOPYRANOSYLOXY)(AZA)INDOLE COMPOUND AND PHARMACEUTICAL CONTAINING THE SAME |
| 08/24/2006 | WO2006087577A2 Inhibition or treatment of dyskinesia |
| 08/24/2006 | WO2006087371A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| 08/24/2006 | WO2006039545A3 Use of parp-1 inhibitors for protecting tumorcidal lymphocytes from apoptosis |
| 08/24/2006 | WO2006023623A3 Methods of healing wounds by administering human il-18 |
| 08/24/2006 | WO2006009464A3 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 08/24/2006 | WO2005120571A3 Method of passive immunization against disease or disorder characterized by amyloid aggregation with diminished risk of neuroinflammation |
| 08/24/2006 | WO2005110484A3 Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration |
| 08/24/2006 | WO2005107726A3 Method for the treatment of back pain |
| 08/24/2006 | WO2005082413A3 Ciclesonide and glycopyrronium combination |
| 08/24/2006 | WO2005074460A9 Methods of enhancing immune response in the intradermal compartment and compounds useful in the methods |
| 08/24/2006 | WO2005018540A3 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
| 08/24/2006 | WO2003070193A3 RNA interference mediated inhibition of HIV gene expression using short interfering nucleic acid (siNA) |
| 08/24/2006 | US20060189669 Pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy and preproliferative retinopathy |
| 08/24/2006 | US20060189651 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 08/24/2006 | US20060189648 Treating with 5-HT3 agonist selecting from (R) N-1-azabicyclo[2.2.2]oct-3-yl-4,7-dihydro-7-oxothieno[3,2-b]pyridine-6-carboxamide; increasing the pressure of the lower esophageal sphincter, suffering from GERD |
| 08/24/2006 | US20060189642 Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases |
| 08/24/2006 | US20060189630 Mitotic kinesin inhibitors |
| 08/24/2006 | US20060189624 Novel combination for treating sexual dysfunction |
| 08/24/2006 | US20060189609 1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 08/24/2006 | US20060189598 substituted azole acid derivatives which modulate blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid levels; hypolipidemic agent; hyperglycemia, hyperinsulinemia, hyperlipidemia, obesity, atherosclerosis; Type 2 diabetes |
| 08/24/2006 | US20060189584 Pharmaceutical combinations |
| 08/24/2006 | US20060189580 1-Adamantyl chalcones for the treatment of proliferative disorders |
| 08/24/2006 | US20060189577 Tyrosine kinase inhibitors |
| 08/24/2006 | US20060189575 Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels |
| 08/24/2006 | US20060189574 Method of treating high plasma cholesterol levels |
| 08/24/2006 | US20060189572 Composition for local anesthesia |
| 08/24/2006 | US20060189563 Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative disease |
| 08/24/2006 | US20060189552 Dispenser for dispensing three or more actives |
| 08/24/2006 | US20060189545 Novel chemical entities and methods for their use in treatment of metabolic disorders |
| 08/24/2006 | US20060189535 Combination treatment using exendins and thiazolidinediones |
| 08/24/2006 | US20060189530 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 08/24/2006 | US20060189525 DADD, death activator death domain protein |
| 08/24/2006 | US20060189500 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 08/24/2006 | US20060188957 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding |
| 08/24/2006 | US20060188953 Methods and compositions that affect melanogenesis |
| 08/24/2006 | US20060188913 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 08/24/2006 | US20060188577 Element having bioactive substance fixed thereto |
| 08/24/2006 | US20060188557 Prepartaion for external percutaneous administration containing non-steroidal anti-inflammatory drug and interleukin-1 alpha production inhibitor |
| 08/24/2006 | US20060188534 Dispersions for the formulation of slightly or poorly soluble agents |
| 08/24/2006 | US20060188521 Disrupting sex steroid signal to thymus: bone marrow or hematopoietic cells |
| 08/24/2006 | US20060188473 Compositions and methods for repressing B cell autoantibody secretion and for treating autoimmune disorders |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | US20060188463 Stable water-in-oil-in-water multiple emulsion system produced by hydrodynamic dual stabilization and a method for preparation thereof |
| 08/24/2006 | US20060188437 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 08/24/2006 | CA2621047A1 Method of treating eye injury with local administration of a vegf inhibitor |
| 08/24/2006 | CA2598484A1 Inhibition or treatment of dyskinesia |
| 08/24/2006 | CA2597269A1 1-substituted-7-(beta-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 08/24/2006 | CA2596922A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| 08/23/2006 | EP1693457A2 Metastatic breast and colon cancer regulated genes |
| 08/23/2006 | EP1693070A1 Procaspase 1 activation inhibitor |
| 08/23/2006 | EP1693052A1 Compositions for delivery of drug combinations |
| 08/23/2006 | EP1692951A1 Topical antifungal composition |
| 08/23/2006 | EP1692507A1 Water-soluble compound |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1692102A2 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 08/23/2006 | EP1691842A1 Treatment of proliferative diseases using an antisense iap oligomer and chemotherapeutic agent |
| 08/23/2006 | EP1691839A1 Combined doses |
| 08/23/2006 | EP1691834A2 Combination therapy |
| 08/23/2006 | EP1691819A2 Chaperone-based therapy for niemann-pick disease |
| 08/23/2006 | EP1691811A1 Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| 08/23/2006 | EP1691809A1 Combination therapy comprising the use of et-743 and paclitaxel for treating cancer |
| 08/23/2006 | EP1691805A1 The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person |
| 08/23/2006 | EP1691801A2 Synergistic anti-cancer compositions |
| 08/23/2006 | EP1691776A2 Treatment of aids |
| 08/23/2006 | EP1691744A2 Methods and reagents for the treatment of inflammatory disorders |
| 08/23/2006 | EP1583524B1 Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer |
| 08/23/2006 | EP1581480B1 Cyclopentyl-substituted glutaramide compounds as endopeptidase-v inhibitors |
| 08/23/2006 | EP1485391B1 Phosphate transport inhibitors |
| 08/23/2006 | EP1399501B1 Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug |
| 08/23/2006 | EP1363920B1 Modified psma ligands and uses related thereto |
| 08/23/2006 | EP1324981B1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |